Profile
PLRZ VRTX REGN SGEN ARGX ALNY
Company Name Polyrizon Ltd. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $2.87M $128.84B $64.28B $43.15B $39.39B $33.74B
Employees 0.00K 6.10K 15.16K 3.26K 1.60K 2.23K
CEO Mr. Tomer Izraeli Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc. Dr. Yvonne L. Greenstreet M.B.A., M.D.
Ratings
PLRZ VRTX REGN SGEN ARGX ALNY
Quant Rating Score 2 4 3 3 1
Quant Rating Sell Buy Neutral Neutral Strong Sell
Trading
PLRZ VRTX REGN SGEN ARGX ALNY
Last Close $0.6535 $434.82 $560.93 $228.74 $622.93 $276.55
High 52 $3.04 $516.74 $1201.76 $228.74 $671.75 $296.75
Low 52 $0.25 $396.64 $546.39 $228.74 $356.01 $146.93
Price vs. 52 Week High -78.5 % -15.85 % -53.32 % 0 % -7.27 % -6.81 %
Price vs. 52 Week Low 161.4 % 9.63 % 2.66 % 0 % 74.98 % 88.22 %
Total Return
PLRZ VRTX REGN SGEN ARGX ALNY
1 Month Return 82.29 % -7.95 % 0.65 % 0 % 13.57 % 23.14 %
3 Month Return -42.17 % -7.35 % -20.94 % 0 % -3.67 % 0.13 %
6 Month Return -45.74 % -15.85 % -32.29 % 0 % 4.52 % -0.32 %
9 Month Return 0 % -6.68 % -49.62 % 0 % 18.6 % 2.25 %
YTD Return -69.88 % 7.98 % -21.25 % 0 % 1.29 % 17.53 %
1 Year Return 0 % 3.82 % -41.31 % 0 % 61.35 % 81.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PLRZ VRTX REGN SGEN ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.15 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -1.65 % 3.85 % -2.27 % -44.32 % -1.49 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
PLRZ VRTX REGN SGEN ARGX ALNY
Gross Profit Margin TTM 86.09 % 84.94 % 72.37 % 46.33 % 86.01 %
Return on Assets TTM -2.38 % 11.98 % -11.76 % 13.45 % -6.4 %
Return on Equity TTM -3.28 % 14.77 % -16.53 % 16.83 % -509.33 %
Return on Capital Employed TTM -1.3 % 11.35 % -16.87 % -0.31 % -3.68 %
Net Income Per EBT TTM -215.53 % 90.27 % 100.55 % 25990.14 % 75.89 %
EBT Per Ebit TTM -100.69 % 129.3 % 94.01 % -18.79 % 308.03 %
EBIT Per Revenue TTM -2.24 % 27.37 % -36.09 % -0.77 % -4.91 %
Cash Flow To Debt Ratio TTM -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Receivables Turnover TTM 6.84 2.53 1.98 2.46 5.62
Payables Turnover TTM 3.71 3.01 1.54 1.83 3.37
Inventory Turnover TTM 1.27 0.66 0.65 2.93 5.01
Fixed Asset Turnover TTM 425.82 % 300.07 % 256.83 % 5106.8 % 337.41 %
Asset Turnover TTM 48.84 % 37.52 % 34.46 % 35.83 % 55.72 %
Operating Cash Flow Per Share TTM -1.91 37.05 -1.12 -1.07 -0.35
Free Cash Flow Per Share TTM -3.07 28.3 -1.62 -1.09 -0.58
Cash Per Share TTM 2375.11 % 7825.12 % 657.5 % 4597.04 % 2024.29 %
Operating Cash Flow Sales Ratio TTM -4.48 % 28.06 % -16.85 % -3.54 % -1.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 160.43 % 76.4 % 144.14 % 102.26 % 167.11 %
Cash Flow Coverage Ratios TTM -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Price To Free Cash Flows Ratio TTM -163.02 21.29 -141.85 -505.86 -447.57
Price To Operating Cash Flows Ratio TTM -261.97 16.35 -203.89 -601.06 -745.64
Price Cash Flow Ratio TTM -261.97 16.35 -203.89 -601.06 -745.64
Income Statement (TTM)
PLRZ VRTX REGN SGEN ARGX ALNY
Revenue $11.02B $14.2B $1.96B $2.19B $2.25B
Gross Profit $9.49B $12.23B $1.55B $1.96B $1.92B
Gross Profit Ratio 86.11% 86.13% 79.1% 89.62% 85.62%
EBITDA $0.48B $5.32B $-0.62B $0B $-0.18B
Net Income $-0.54B $4.41B $-0.61B $0.83B $-0.28B
EPS Diluted -2.08 38.34 -3.3 12.78 -2.16
Balance Sheet (MRQ)
PLRZ VRTX REGN SGEN ARGX ALNY
Long Term Debt $1.66B $1.98B $0.04B $0.03B $0B
Total Liabilities $6.12B $8.41B $0.87B $0.7B $4.17B
Total Equity $16.41B $29.35B $2.8B $5.5B $0.07B
Total Investments $6.65B $15.42B $1.42B $1.93B $1.73B
Total Debt $1.75B $2.7B $0.04B $0.04B $1.3B
Total Assets $22.53B $37.76B $3.67B $6.2B $4.3B
Cash Flow Statement (TTM)
PLRZ VRTX REGN SGEN ARGX ALNY
Net Income $-0.54B $4.41B $-0.61B $0.8B $-0.28B
Inventory $-0.52B $-0.62B $-0.23B $-0.09B $0.01B
Dividends Paid $0B $0B $0B $0B $0B
Operating Cash Flow $-0.49B $4.42B $-0.45B $-0.08B $-0.01B
Capital Expenditure $-0.3B $-0.76B $-0.08B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 25.16
ABCL AbCellera Biologics Inc. 2.005
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.48
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1
ABPWW 0.02
ABSI Absci Corporation 2.79
ABUS Arbutus Biopharma Corporation 3.295
ABVC ABVC BioPharma, Inc. 1.31
ABVX Abivax SA American Depositary Shares 6.87
ACAD ACADIA Pharmaceuticals Inc. 16.95
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.4785
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.44
ACIU AC Immune SA 1.645
ACLX Arcellx, Inc. 56.08
Unlock